
Dalian BIO-CHEM Company Limited
SSE:603360.SS
28.36 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||
Current Assets: | ||||||||||||||
Cash & Cash Equivalents
| 668.244 | 539.524 | 417.963 | 293.879 | 333.068 | 242.124 | 71.605 | 134.245 | 114.085 | 26.758 | 36.7 | 51.013 | 20.889 | 37.784 |
Short Term Investments
| 0 | 60.015 | -0.584 | 0.628 | 10.336 | -2.123 | 130 | 100.613 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 668.244 | 599.538 | 417.963 | 294.507 | 343.405 | 242.124 | 71.605 | 134.245 | 114.085 | 26.758 | 36.7 | 51.013 | 20.889 | 37.784 |
Net Receivables
| 551.582 | 390.323 | 176.601 | 192.874 | 134.204 | 160.417 | 102.767 | 134.387 | 92.867 | 81.027 | 78.998 | 58.917 | 54.022 | 0 |
Inventory
| 902.354 | 206.935 | 181.036 | 186.732 | 106.111 | 95.231 | 65.834 | 47.59 | 51.471 | 57.913 | 60.716 | 66.736 | 57.341 | 35.141 |
Other Current Assets
| 390.854 | 70.639 | 297.047 | 72.121 | 51.178 | 34.736 | 57.243 | 107.58 | 9.066 | 84.646 | 10.812 | 13.75 | 16.826 | 46.988 |
Total Current Assets
| 2,513.034 | 1,267.435 | 1,050.477 | 727.77 | 611.515 | 521.797 | 298.053 | 425.178 | 264.148 | 169.317 | 182.566 | 184.736 | 143.361 | 119.913 |
Non-Current Assets: | ||||||||||||||
Property, Plant & Equipment, Net
| 696.43 | 619.507 | 630.405 | 825.835 | 542.565 | 425.623 | 340.763 | 250.307 | 248.381 | 268.262 | 269.359 | 252.821 | 242.178 | 230.745 |
Goodwill
| 230.532 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.939 | 1.939 | 1.939 | 1.939 | 1.939 |
Intangible Assets
| 137.206 | 42.17 | 43.183 | 92.157 | 93.361 | 95.728 | 85.448 | 77.175 | 79.092 | 80.927 | 82.698 | 84.407 | 86.288 | 88.17 |
Goodwill and Intangible Assets
| 367.738 | 42.17 | 43.183 | 92.157 | 93.361 | 95.728 | 85.448 | 77.175 | 79.092 | 82.866 | 84.638 | 86.346 | 88.228 | 90.109 |
Long Term Investments
| 0 | -52.999 | 14.474 | 1.221 | 121.975 | 133.737 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 28.407 | 60.015 | 11.198 | 17.817 | 11.62 | 11.922 | 25.077 | 25.08 | 30.572 | 27.015 | 23.553 | 19.856 | 17.292 | 16.045 |
Other Non-Current Assets
| 34.16 | 65.591 | 4.655 | 5.923 | 48.66 | 0.49 | 148.041 | 1.591 | 4.175 | 0.792 | 4.878 | 3.019 | 2.443 | 1.953 |
Total Non-Current Assets
| 1,126.736 | 674.269 | 703.915 | 942.952 | 818.181 | 667.5 | 599.329 | 354.152 | 362.219 | 378.935 | 382.427 | 362.041 | 350.141 | 338.852 |
Total Assets
| 3,639.77 | 1,941.704 | 1,754.392 | 1,670.722 | 1,429.696 | 1,189.297 | 897.382 | 779.33 | 626.368 | 548.252 | 564.993 | 546.778 | 493.501 | 458.764 |
Liabilities & Equity: | ||||||||||||||
Current Liabilities: | ||||||||||||||
Account Payables
| 117.719 | 62.64 | 66.775 | 142.021 | 65.372 | 44.942 | 35.577 | 27.731 | 19.652 | 17.524 | 24.359 | 33.616 | 48.347 | 59.481 |
Short Term Debt
| 423.938 | 150.012 | 129.113 | 338.505 | 300 | 30.047 | 0 | 0 | 75 | 100 | 160 | 132.1 | 112 | 83 |
Tax Payables
| 49.783 | 18.148 | 3.334 | 2.053 | 16.122 | 16.32 | 2.441 | 7.039 | 9.717 | 4.168 | 5.299 | 3.398 | 3.061 | 22.173 |
Deferred Revenue
| 0 | 2.35 | 2.152 | 56.102 | 30.557 | 26.338 | 1.81 | 1.058 | 15.642 | 8.941 | 12.915 | 7.735 | 6.797 | 25.735 |
Other Current Liabilities
| 521.087 | 36.655 | 39.487 | 49.935 | 11.114 | 14.945 | 9.77 | 7.065 | 6.124 | 5.419 | 8.057 | 5.599 | 4.051 | 39.981 |
Total Current Liabilities
| 1,112.527 | 269.804 | 240.861 | 536.888 | 396.049 | 106.254 | 47.788 | 41.835 | 110.493 | 127.111 | 198.672 | 174.713 | 167.459 | 204.635 |
Non-Current Liabilities: | ||||||||||||||
Long Term Debt
| 108.605 | 0.382 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.8 | 29.9 | 0 |
Deferred Revenue Non-Current
| 8.055 | 9.342 | 10.628 | 37.325 | 41.091 | 44.858 | 46.348 | 51.074 | 55.8 | 60.227 | 63.162 | 65.12 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 52.896 | 25.457 | 41.631 | 36.854 | 4.272 | 4.717 | 5.212 | 0 | 0 | 0 | 0 | -65.12 | 0 | 0 |
Other Non-Current Liabilities
| 6.489 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 1.984 | 0.741 | 0 | 65.12 | 67.918 | 70.716 |
Total Non-Current Liabilities
| 176.046 | 35.181 | 52.26 | 84.179 | 45.363 | 49.575 | 51.56 | 51.074 | 57.783 | 60.968 | 63.162 | 94.92 | 97.818 | 70.716 |
Total Liabilities
| 1,288.573 | 304.985 | 293.121 | 621.067 | 441.413 | 155.828 | 99.348 | 92.909 | 168.277 | 188.079 | 261.834 | 269.633 | 265.277 | 275.351 |
Equity: | ||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.019 | 0 | 0 | 0 |
Common Stock
| 504.445 | 360.318 | 258.952 | 261.346 | 261.346 | 186.676 | 186.676 | 133.34 | 100 | 100 | 100 | 100 | 100 | 75 |
Retained Earnings
| 1,001.529 | 1,050.118 | 1,058.995 | 656.429 | 574.691 | 485.973 | 279.105 | 182.353 | 227.623 | 140.959 | 90.444 | 71.815 | 28.673 | 29.186 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 148.753 | 139.702 | 114.96 | 93.971 | 66.714 | 51.666 | 39.444 | 119.636 | -0.019 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 282.5 | 226.282 | -5.428 | -7.823 | 37.285 | 266.848 | 333.562 | 371.85 | 131.266 | 119.556 | 112.733 | 105.33 | 99.551 | 79.228 |
Total Shareholders Equity
| 1,788.474 | 1,636.719 | 1,461.271 | 1,049.655 | 988.283 | 1,033.468 | 799.343 | 687.543 | 458.889 | 360.595 | 303.158 | 277.145 | 228.224 | 183.413 |
Total Equity
| 2,351.197 | 1,636.719 | 1,461.271 | 1,049.655 | 988.283 | 1,033.468 | 798.033 | 686.421 | 458.091 | 360.174 | 303.158 | 277.145 | 228.224 | 183.413 |
Total Liabilities & Shareholders Equity
| 3,639.77 | 1,941.704 | 1,754.392 | 1,670.722 | 1,429.696 | 1,189.297 | 897.382 | 779.33 | 626.368 | 548.252 | 564.993 | 546.778 | 493.501 | 458.764 |